Menu
Recent Quotes
My Watchlist
Indicators
Markets
Stocks
ETFs
Tools
Markets:
Overview
News
Currencies
International
Treasuries

Johnson & Johnson (NY:JNJ)

194.42 +0.59 (+0.30%)
Streaming Delayed Price Updated: 12:22 PM EST, Nov 12, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
Press Releases
Research
Quarterly Reports Insider Filings Other Filings

All News about Johnson & Johnson

< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Johnson & Johnson's Tecvayli-Darzalex Combo Shows 100% Response In Newly Diagnosed Myeloma Patients
Johnson & Johnson's Tecvayli-Darzalex regimen showed 100% response rates and high MRD negativity in newly diagnosed multiple myeloma patients. 
Via Benzinga
Can Regeneron Change The Paradigm In Multiple Myeloma — And Undercut J&J?
The company is looking to take on Johnson & Johnson in treating patients with a precursor to multiple myeloma. 
Via Investor's Business Daily
Recent Report Shows That Rep. Thomas Kean Bought Up to $45K Worth of Amcor Stock
 
Via Benzinga
8 Dividend Growth Stocks Every Investor Should Consider
These dividend powerhouses compound wealth through decades of consecutive increases and sustainable payout ratios. 
Via The Motley Fool
Topics Artificial Intelligence Economy
J&J’s Investigational Plaque Psoriasis Drug Outperforms Bristol Myers’ Sotyktu In Study
Via Stocktwits
Big Pharma Eyes China: J&J And Roche Reportedly In Talks For Henlius’ Experimental Cancer Drug
Via Stocktwits
Melanoma Data Study Boosts J&J Partner Nanobiotix Stock On Thursday
Nanobiotix reported melanoma study data showing JNJ-1900 delivered 47.4% response rate, 78.9% disease control, and 14.6 months survival. 
Via Benzinga
Intuitive Surgical: A Steady Hand in a Storm of AI Hype?
In a financial landscape increasingly dominated by the exhilarating, often volatile, narrative of artificial intelligence, Intuitive Surgical (NASDAQ: ISRG) stands as a testament to steady, fundamental... 
Via MarketMinute
Topics Artificial Intelligence Supply Chain
Federal Reserve Navigates Stagflationary Headwinds with Dovish Pivot
Washington D.C. - The U.S. Federal Reserve finds itself at a critical juncture, facing an economic environment that is increasingly raising the specter of "stagflation" – a challenging combination of... 
Via MarketMinute
Topics Economy Supply Chain World Trade
What the Options Market Tells Us About Johnson & Johnson
 
Via Benzinga
The Specter of Stagflation: Is the Economy Headed for Stagnant Growth and High Inflation?
The U.S. Federal Reserve’s recent decision to cut interest rates has sent a tremor of concern through financial markets, sparking fears of a potential return to stagflation—an economic phenomenon... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Johnson & Johnson, Protagonist Study Shows Superior Skin Clearance In Psoriasis Trials
Johnson & Johnson and Protagonist Therapeutics announced new data from their Phase 3 studies to treat severe plaque psoriasis. 
Via Benzinga
Intuitive Surgical's Stellar Q2 2025 Performance Propels Robotic Surgery Market Forward
Sunnyvale, CA – September 17, 2025 – Intuitive Surgical (NASDAQ: ISRG), the pioneer and global leader in robotic-assisted surgery, has once again demonstrated its formidable market position with a... 
Via MarketMinute
Topics Artificial Intelligence Supply Chain
A Precarious Ascent: Stock Market Bulls Grapple with Stubborn Inflation and a Cooling Job Market
The financial markets find themselves in a fascinating, if precarious, dance. Despite a recent surge in stock market performance, with the S&P 500 ([SPX]) registering robust gains in recent years,... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Johnson & Johnson (NYSE:JNJ): A Dividend Stock with Lasting Financial Strength
Johnson & Johnson (JNJ) is a top dividend stock with a 2.91% yield, over 10 years of growth, and strong financials for reliable income. 
Via Chartmill
GSK Stock Climbs After-Hours On $30B US Investment Pledge As Trump Pressures Big Pharma To Build In America
The plan includes $1.2 billion for a new biologics factory in Upper Merion, Pennsylvania, along with AI upgrades and expanded drug production across existing U.S. sites. 
Via Stocktwits
Topics Artificial Intelligence Government World Trade
Navigating the Storm: Investment Strategies for an Unpredictable 2025
The financial landscape is bracing for a turbulent 2025, as expert consensus points towards a significant uptick in market volatility. This anticipated shift, driven by a complex interplay of global... 
Via MarketMinute
Topics Artificial Intelligence Bonds Climate Change
3 Dividend Stocks to Hold Through Market Volatility This Fall
Interest rate cuts may not decrease market volatility; discover three dividend stocks that can deliver stability, income, and growth during this fall 
Via MarketBeat
Topics Economy
Monetary Easing on the Horizon: Investors Brace for 2025 Rate Cuts, Fueling a Shift to Risk Assets
Central banks worldwide, spearheaded by the U.S. Federal Reserve, are signaling a significant pivot towards monetary easing in 2025. This anticipated shift, driven by a weakening labor market and... 
Via MarketMinute
Topics Bonds Economy Supply Chain
Market Mania Meets Economic Malaise: Record Highs Clash with Persistent Headwinds in Q3 2025
The third quarter of 2025 has been a period of stark contrasts for the global financial markets. While major U.S. stock indices like the S&P 500 and the Dow Jones Industrial Average (DJIA) have soared... 
Via MarketMinute
Topics Economy Intellectual Property Stocks
3 Dividend-Paying ETFs to Buy in September Even If the S&P 500 Sells Off
Dividend-paying growth stocks and covered call ETFs provide opportunities to generate income even in a declining stock market. 
Via The Motley Fool
Topics ETFs Stocks
3 Dividend Growers That Fly Under the Radar
These three companies may have what it takes to continue to build on their strong history of dividend payments even if the economy continues to sour. 
Via MarketBeat
Topics Earnings Economy
A Gathering Storm: U.S. Economy Grapples with Recessionary Headwinds
The United States economy is facing an increasingly complex and concerning confluence of risk factors, raising the specter of a looming recession. A deteriorating labor market, persistently high... 
Via MarketMinute
Topics Artificial Intelligence Economy Supply Chain
Navigating the Shifting Sands: A Comprehensive Economic Outlook for 2025
As the global economy marches into 2025, it finds itself at a critical juncture, balancing the promise of moderate growth against the persistent shadows of tenacious inflation, geopolitical... 
Via MarketMinute
Topics Artificial Intelligence Bonds Economy
Recession Radar: A Divergent Outlook on America's Economic Future
The U.S. economy finds itself at a crossroads, with leading financial institutions and economic forecasters presenting a varied, yet generally cautious, outlook on the probability of a recession. From... 
Via MarketMinute
Topics Bonds Economy Supply Chain
Stalling Job Market Rings Alarm Bells: August Employment Data Signals Economic Headwinds and Intensified Rate Cut Expectations
The latest U.S. employment report for August 2025 has sent a palpable chill through financial markets and economic forecasts, confirming a significant deceleration in the nation's labor market.... 
Via MarketMinute
Topics Bonds Economy Workforce
Federal Reserve's Unexpected September Hold: A Looming Market Shock and an Estimated 8% S&P 500 Plunge
Financial markets are currently on edge, grappling with the looming possibility of a significant shock: an unexpected decision by the Federal Reserve to forgo a widely anticipated interest rate cut in... 
Via MarketMinute
Topics Bonds ETFs Economy
September's Shadow: Will the Notorious 'September Effect' Offer Bargains or Bring Bigger Bears to Wall Street?
As autumn leaves begin to fall, a familiar chill often descends upon the financial markets, not just in temperature but in investor sentiment. September has historically earned a notorious reputation... 
Via MarketMinute
Topics Artificial Intelligence Economy Stocks
S&P 500's 22x Forward P/E: A Precarious Peak or Justified Premium?
The S&P 500's current forward price-to-earnings (P/E) ratio, hovering around 22x, has ignited a fervent debate across financial markets. This elevated valuation metric, significantly above historical... 
Via MarketMinute
Topics Artificial Intelligence Bonds ETFs
If You'd Invested $1,000 in Johnson & Johnson (JNJ) Stock 5 Years Ago, Here's How Much You'd Have Today
The answer might surprise you. 
Via The Motley Fool
< Previous 1 2
...
6 7 8 9 10 11 12 13 14
...
99 100 Next >
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.